OPNT CEO Discusses The State Of The Opioid Crisis

<p>The CEO of Opiant Pharmaceuticals (OPNT), Dr. Roger Crystal, says that the company develops treatments for substance use, as well as addictive and eating disorders. Their breakthrough naloxone nasal spray treatments are FDA approved for treatment of opioid overdose. The stock is up 32% in 2021.</p>